Glenmark Pharmaceuticals: Announcement under Regulation 30 (LODR)-Press Release / Media Release

Glenmark Pharmaceuticals Inc. USA to launch Potassium Phospohates Injection USP 15 mmol P / 22 mEq K per 5 mL and 45 mmol P / 66 mEq K per 15 mL Single-Dose Vials and 150 mmol P / 220 mEq K per 50 mL Pharmacy Bulk Package Vials.